Rockwell Medical, Inc.
RMTI
$1.03
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 50.00% | 188.89% | 110.38% | 1.09% | 35.99% |
| Total Depreciation and Amortization | -1.27% | -3.72% | 222.94% | 240.63% | 257.14% |
| Total Amortization of Deferred Charges | -89.29% | -4.35% | -67.39% | 138.04% | 793.55% |
| Total Other Non-Cash Items | 64.55% | -28.88% | -15.60% | 13.40% | -41.26% |
| Change in Net Operating Assets | 100.98% | 120.29% | -140.82% | 28.59% | -151.78% |
| Cash from Operations | 2,111.63% | 213.91% | 182.87% | 38.60% | 61.61% |
| Capital Expenditure | -818.60% | -1,093.75% | -257.50% | 4.14% | 48.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -96.93% | -383.84% | 12,418.75% | -- | -37.89% |
| Cash from Investing | -116.53% | 40.61% | 2,782.81% | -102.62% | -37.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 81.74% | 61.03% | -6.15% | 39.46% | 68.62% |
| Issuance of Common Stock | 244.99% | -73.62% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,818.42% | -2,169.77% | -- | -- | -- |
| Cash from Financing | 476.28% | -81.99% | 1,688.46% | 128.21% | 87.60% |
| Foreign Exchange rate Adjustments | -200.00% | 0.00% | -200.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 171.57% | 139.58% | 369.82% | -395.58% | 142.53% |